General Information of the Protein
Protein ID |
PT01588
|
||||
---|---|---|---|---|---|
Protein Name |
Corticotropin-releasing factor receptor 1
|
||||
Secondarily Protein Name |
Corticotropin-releasing hormone receptor 1
|
||||
Gene Name |
CRHR1
|
||||
Secondarily Gene Name |
CRFR
CRFR1
CRHR
|
||||
Sequence |
MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDLIGTCWPRSPAGQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYSECQEILNEEKKSKVHYHVAVIINYLGHCISLVALLVAFVLFLRLRPGCTHWGDQADGALEVGAPWSGAPFQVRRSIRCLRNIIHWNLISAFILRNATWFVVQLTMSPEVHQSNVGWCRLVTAAYNYFHVTNFFWMFGEGCYLHTAIVLTYSTDRLRKWMFICIGWGVPFPIIVAWAIGKLYYDNEKCWFGKRPGVYTDYIYQGPMILVLLINFIFLFNIVRILMTKLRASTTSETIQYRKAVKATLVLLPLLGITYMLFFVNPGEDEVSRVVFIYFNSFLESFQGFFVSVFYCFLNSEVRSAIRKRWHRWQDKHSIRARVARAMSIPTSPTRVSFHSIKQSTAV
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Membrane receptor
>
Family B G protein-coupled receptor
>
Peptide receptor (family B GPCR)
>
Corticotropin releasing factor receptor
>
Corticotropin releasing factor receptor
|
||||
Function |
G-protein coupled receptor for CRH (corticotropin-releasing factor) and UCN (urocortin). Has high affinity for CRH and UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels. Inhibits the activity of the calcium channel CACNA1H. Required for normal embryonic development of the adrenal gland and for normal hormonal responses to stress. Plays a role in the response to anxiogenic stimuli.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Cell membrane
Endosome
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000367 , AtT-20
Cell Line ID: CL000011 , CHO
Cell Line ID: CL000026 , CHO-K1
Cell Line ID: CL000583 , COS-M6
Cell Line ID: CL000025 , HEK-293T
Cell Line ID: CL000809 , HEK273
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000065 , HEK293-EBNA
Cell Line ID: CL000017 , HeLa
Cell Line ID: CL000016 , IMR-32
Cell Line ID: CL000041 , LTK-
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Corticotropin-releasing factor receptor 1 (CRHR1) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 5 Target-related Diseases | 5 | |||
1 | Anxiety disorder [ICD-11: 6B00-6B0Z] | ||||
2 | Major depressive disorder [ICD-11: 6A70.3] | ||||
3 | Mood disorder [ICD-11: 6A60-6E23] | ||||
4 | Irritable bowel syndrome [ICD-11: DD91.0] | ||||
5 | Depression [ICD-11: 6A70-6A7Z] | ||||
Clinical Trial Drug(s) | 4 Clinical Trial Drugs | 4 | |||
1 | Pexacerfont | Phase 2/3 | |||
2 | GSK561679 | Phase 2 | |||
3 | ONO-2333Ms | Phase 2 | |||
4 | SSR125543 | Phase 2 | |||
Discontinued Drug(s) | 4 Discontinued Drugs | 4 | |||
1 | CP-316,311 | Discontinued in Phase 2 | |||
2 | GW876008 | Discontinued in Phase 2 | |||
3 | Antalarmin | Terminated | |||
4 | DMP-696 | Terminated | |||
Investigative Drug(s) | 3 Investigative Drugs | 3 | |||
1 | BMS-561388 | Investigative | |||
2 | CP154,526 | Investigative | |||
3 | Des-Arg(9)-[Leu(8)]-BK | Investigative |